7,772 results
·
36ms
·
Sources: EU EUDAMED, US FDA
Filters
Device
×
Rotor KRG
Device
EU MDR
·
Eu Md Class 1
·Biuro Handlowe Kinesis Andrzej Boruta·On the market
immunoLINE IgE Nutritional KW1
Device
EU IVDD
·
Eu Ivd General
·Gold Standard Diagnostics Kassel GmbH·On the market
SYRINGE SHIELD, PET DOSE DWG, 3cc, TUNG
Device
EU MDR
·
Eu Md Class 1
·Mirion Technologies (Capintec), Inc.·On the market·32 countries
SYRINGE SHIELD, PET DOSE DWG, 5cc, TUNG
Device
EU MDR
·
Eu Md Class 1
·Mirion Technologies (Capintec), Inc.·On the market·32 countries
SHIELD, SYRINGE, 10/12cc, DOSE DWG, LUER
Device
EU MDR
·
Eu Md Class 1
·Mirion Technologies (Capintec), Inc.·On the market·32 countries
SHIELD, SYRINGE, 3cc DOSE DWG, NON-LUER
Device
EU MDR
·
Eu Md Class 1
·Mirion Technologies (Capintec), Inc.·On the market·32 countries
SHIELD, SYRINGE, 5/6cc,DOSE DWG,NON-LUER
Device
EU MDR
·
Eu Md Class 1
·Mirion Technologies (Capintec), Inc.·On the market·32 countries
Olivia
Device
EU MDR
·
Eu Md Class 1
·Intigena (Schweiz) AG·Not intended for eu market
Olivia
Device
EU MDR
·
Eu Md Class 1
·Intigena (Schweiz) AG·Not intended for eu market
Secure
Device
EU MDR
·
Eu Md Class 1
·Intigena (Schweiz) AG·Not intended for eu market
Genopharm
Device
EU MDR
·
Eu Md Class 1
·Intigena (Schweiz) AG·On the market
Genopharm
Device
EU MDR
·
Eu Md Class 1
·Intigena (Schweiz) AG·On the market
Secure
Device
EU MDR
·
Eu Md Class 1
·Intigena (Schweiz) AG·Not intended for eu market
Secure
Device
EU MDR
·
Eu Md Class 1
·Intigena (Schweiz) AG·Not intended for eu market
Secure
Device
EU MDR
·
Eu Md Class 1
·Intigena (Schweiz) AG·Not intended for eu market
Royal Excellence
Device
EU MDR
·
Eu Md Class 1
·Intigena (Schweiz) AG·Not intended for eu market
Royal Excellence
Device
EU MDR
·
Eu Md Class 1
·Intigena (Schweiz) AG·Not intended for eu market
Royal Excellence
Device
EU MDR
·
Eu Md Class 1
·Intigena (Schweiz) AG·Not intended for eu market
ROTOLAVIT II
Device
EU IVDR
·
Eu Ivd Class A
·Hettich AG·On the market
ROTOLAVIT II-S
Device
EU IVDR
·
Eu Ivd Class A
·Hettich AG·On the market